Xenon Pharmaceuticals CEO Simon Pimstone's 2019 pay jumps 124% to $2.6M
Xenon Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 28, 2020
Xenon Pharmaceuticals reported fiscal year 2019 executive compensation information on April 28, 2020.
In 2019, three executives at Xenon Pharmaceuticals received on average a compensation package of $1.7M, a 88% increase compared to previous year.
Average pay of disclosed executives at Xenon Pharmaceuticals
Simon N. Pimstone, Chief Executive Officer, received $2.6M in total, which increased by 124% compared to 2018. 69% of Pimstone's compensation, or $1.8M, was in option awards. Pimstone also received $334K in non-equity incentive plan, $446K in salary, as well as $31K in other compensation.
Ian C. Mortimer, Chief Financial Officer, received a compensation package of $1.6M, which increased by 68% compared to previous year. 56% of the compensation package, or $869K, was in option awards.
Ernesto Aycardi, Chief Medical Officer, earned $1.1M in 2019, a 55% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2020.